Pharma and Healthcare - Q2FY27E: Result Preview
We expect pharmaceutical companies under our coverage to deliver a subdued yet positive performance in Q2FY27, with aggregate revenue rising 7.0%...
90 Views
Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact
Revenue Growth Moderates: Max Healthcare reported net revenue of Rs 2,835 Cr, up 15% YoY and 12% QoQ (gross revenue at Rs 2,982 Cr, up 16% YoY),...
98 Views
Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact
Revenue Growth Moderates: Max Healthcare reported net revenue of Rs 2,484 Cr, up 9% YoY but down 3.7% QoQ, moderately below expectations.
152 Views
Max Healthcare Institute: Steady Growth Visbility, Margin Hinges on Execution. Upgrade to ADD
Max Healthcare (MAXHEALTH) is on track with its capex plan to add over 3,000 beds between FY26 and FY28 (~2,100 brownfield and 900 greenfield beds)
224 Views
Max Healthcare Institute: Steady Growth Visbility, Margin Hinges on Execution.
Max Healthcare (MAXHEALTH) is on track with its capex plan to add over 3,000 beds between FY26 and FY28 (~2,100 brownfield and 900 greenfield beds)
172 Views